Commentary: A new hope-neoadjuvant immunotherapy for resectable non-small cell lung cancer

J Thorac Cardiovasc Surg. 2022 Feb;163(2):439-440. doi: 10.1016/j.jtcvs.2021.04.056. Epub 2021 Apr 27.

Authors

Ramiro Fernandez¹, Usman Ahmad²

Affiliations

¹ Department of Cardiothoracic Surgery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
² Department of Cardiothoracic Surgery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: [email protected].

PMID: 34024619
DOI: 10.1016/j.jtcvs.2021.04.056

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / therapy
Humans
Immunotherapy
Lung Neoplasms* / therapy
Neoadjuvant Therapy